Dr Efstathiou on the Evolution of Trimodal Therapy in MIBC
Jason Efstathiou, MD, DPhil, discusses the utility of trimodal therapy in patients with muscle-invasive bladder cancer.
Source: onclive.com
Stay updated with breaking news from Jason Efstathiou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jason Efstathiou, MD, DPhil, discusses the utility of trimodal therapy in patients with muscle-invasive bladder cancer.
Jason Efstathiou, MD, discusses the status of bladder preservation therapy for muscle-invasive bladder cancer.
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the Class of 2021 Young Investigator Award recipients totaling nearly $6.5 million in...